0NR

UNIPHAR PLC EO -08

Healthcare · EUR · F

0NR

Price

€4.478

+0.16%

Cap

€986.28M

Earnings

30d Trend

+12.4%

0NR
Loading chart data...
0 days · % change from startPowered by Brain47

BRAIN47 SIGNAL

0
STRONG
Risk Level49
Quality57
Momentum68
Technical66
Fundamentals72

Raw weighted: 64×Macro 0.99 (1%)=63

RISK

49/100
90d Volatility
27.3%Moderate
ATR %
3.8%High daily moves
Max Drawdown (1Y)
-15.4%Normal

QUALITY

57/100
ROE (avg)
12.7%Good
Piotroski F-Score
5/9Average
Debt/Equity
1.60High leverage
Margin Stability
CV 3.4%Very stable
Accruals
-3.3%Cash earnings
Interest Coverage
4.5xAdequate

MOMENTUM

68/100
12-1M Momentum
+20.3%Strong uptrend
6-1M Momentum
+10.8%Positive
1M Return
+9.3%Strong recent gains
Relative Strength
-0.0% vs sectorIn-line

TECHNICAL

66/100
RSI (14)
69.0Neutral
Price vs SMA200
+14.9%Bullish trend
MACD
+1.67Bullish momentum
Bollinger Band
82%Near upper band
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.549Mixed

FUNDAMENTALS

72/100
EV/EBIT
15.9Fair
P/FCF
11.6Cheap
P/S
0.3Cheap
Shareholder Yield
4.1%Moderate

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months63
3-12 months76
1-5+ years68

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate UNIPHAR PLC EO -08 at 63/100 — a STRONG reading on the Brain47 Signal. The strongest factor is fundamentals at 72/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Fundamentals (72) and Momentum (68) are the primary strengths. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.

growthScore: 63/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.